Francis Murgatroyd

An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

Gust H. Bardy, Warren Smith, Margaret Hood et al. · New England Journal of Medicine · 2010 · 774 citations · Full text

Medicine, Biomedical Engineering, Cardiology +9

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

Jean‐Claude Daubert, Leslie A. Saxon, Philip B. Adamson et al. · Heart Rhythm · 2012 · 479 citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +14

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management: A registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society; and in collaboration with the Heart Failure Society of America (HFSA), the American Society of Echocardiography (ASE), the American Heart Association (AHA), the European Association of Echocardiography (EAE) of the ESC and the Heart Failure Association of the ESC (HFA). * Endorsed by the governing bodies of AHA, ASE, EAE, HFSA, HFA, EHRA, and HRS

Jean‐Claude Daubert, Leslie A. Saxon, Philip B. Adamson et al. · EP Europace · 2012 · 257 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator

Paul A. Friedman, Francis Murgatroyd, Lucas V.A. Boersma et al. · New England Journal of Medicine · 2022 · 227 citations · Full text

Medicine, Cardiology, Surgery +14

Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans

Francis Murgatroyd, Alistair Slade, S. Mark Sopher et al. · Journal of the American College of Cardiology · 1995 · 211 citations

Medicine, Cardiology, Clinical Cardiology +9